Edwards Lifesciences Corporation Retained Earnings
Edwards Lifesciences Corporation (EW) had Retained Earnings of $14.86 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) $14.86B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $14.62B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $14.24B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $14.15B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | $14.86B 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $14.62B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $14.24B 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $14.15B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $13.86B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $13.53B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $13.17B 10-K · filed 2026-02-25 | |
| 2024-09-30 | $12.78B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $9.71B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $9.34B 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $8.99B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $8.62B 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $8.24B 10-Q · filed 2023-07-28 | |
| 2023-03-31 | $7.93B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $7.59B 10-K · filed 2024-02-12 | |
| 2022-09-30 | $7.19B 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $6.85B 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $6.44B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $6.07B 10-K · filed 2023-02-13 | |
| 2021-09-30 | $5.73B 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $5.39B 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $4.90B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $4.57B 10-K · filed 2022-02-14 | |
| 2020-09-30 | $4.26B 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $3.93B 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $4.05B 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $3.74B 10-K · filed 2021-02-12 | |
| 2019-09-30 | $3.46B 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $3.19B 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $2.94B 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $2.69B 10-K · filed 2020-02-14 | |
| 2018-09-30 | $2.69B 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $2.46B 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $2.18B 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $1.96B 10-K · filed 2019-02-15 | |
| 2017-09-30 | $1.96B 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $4.33B 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $4.15B 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $3.91B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $3.75B 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $3.61B 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $3.48B 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $3.34B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $3.20B 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $3.08B 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $2.97B 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $2.84B 10-K · filed 2016-02-19 | |
| 2014-09-30 | $2.73B 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $2.64B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $2.09B 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $2.03B 10-K · filed 2015-02-20 | $2.05B 10-K · filed 2014-02-28 |
| 2013-09-30 | $1.97B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $1.89B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $1.80B 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $1.65B 10-K · filed 2014-02-28 | |
| 2012-09-30 | $1.56B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $1.49B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.43B 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $1.36B 10-K · filed 2013-02-28 | |
| 2011-09-30 | $1.30B 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $1.25B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $1.19B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $1.12B 10-K · filed 2012-02-27 | |
| 2010-09-30 | $1.06B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $1.01B 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $906.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |